Journals / İstanbul Tıp Fakültesi Dergisi / 2023 / Cilt: 86 - Sayı: 1

ASSOCIATING eNOS GENE VARIANTS WITH COVID-19 SUSCEPTIBILITY IN THE TURKISH POPULATION

TÜRK POPÜLASYONUNDA COVID-19 DUYARLILIĞI İLE eNOS VARYANTLARININ İLİŞKİSİ

Pages
1–6
Publication Date
2023-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further research is required to understand the molecular mechanisms involved in the pathogenesis of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: COVID-19 is a serious respiratory and vascular disease that impairs the protective function of the endothelial barrier.
📊
Key Findings & Data:Therefore, this study aims to evaluate whether eNOS G894T and variable tandem repeat number (VNTR) functional variants show predisposition to developing COVID-19.
💡
Conclusion & Impact:Further research is required to understand the molecular mechanisms involved in the pathogenesis of the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · nitrik oksit sentaz · varyant

Abstract

Objective: COVID-19 is a serious respiratory and vascular disease that impairs the protective function of the endothelial barrier. Endothelial nitric oxide synthase (eNOS), the most important isoform for nitric oxide (NO) production, is mostly expressed in endothelial cells. Therefore, this study aims to evaluate whether eNOS G894T and variable tandem repeat number (VNTR) functional variants show predisposition to developing COVID-19. Materials and Methods: The study includes a total of 384 subjects (284 COVID-19 patients and 100 healthy controls). Two eNOS gene variants (G894T and VNTR) were genotyped using the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods, with the results being evaluated using statistical methods. Results: A significant association has been identified between eNOS G894T and COVID-19. For the eNOS G894T variant, the T/T genotype (p=0.035) and T allele carriers (p=0.030) appear to have an increased risk of developing COVID-19. The eNOS G894T G/G genotype (p=0.030) was more common in the control group compared to the patient group. No significant difference was found between groups regarding the eNOS VNTR genotype and allele frequencies (p˃0.05). The genotypes of the patient and control groups for these variants were in Hardy-Weinburg equilibrium (HWE). Conclusion: These results provide evidence supporting the hypothesis that the eNOS G894T variant is associated with an increased risk of developing COVID-19 in the Turkish population. These findings may lead to the emergence of new treatment options. Further research is required to understand the molecular mechanisms involved in the pathogenesis of the disease.

Özet

Amaç: Ciddi bir solunum ve damar hastalığı olan COVID-19 hastalığında endotel bariyerinin koruyucu işlevi bozulmaktadır. Nitrik oksid (NO) üretimi için en önemli izoform olan endotelyal NO sentaz (eNOS), çoğunlukla endotel hücrelerinde eksprese edilir. Bu nedenle, bu çalışma, eNOS G894T ve değişken ardışık tekrar sayısı (VNTR) fonksiyonel varyantlarının COVID-19 hastalığının gelişimine yatkınlık oluşturup oluşturmadığını değerlendirmeyi amaçladı. Gereç ve Yöntem: Bu çalışmaya toplam 384 birey (284 COVID-19 hastası ve 100 sağlıklı kontrol) dahil edildi. İki eNOS gen varyantı (G894T ve VNTR), polimeraz zincir reaksiyonu (PCR) ve/ veya kısıtlama fragman uzunluğu polimorfizmi (RFLP) yöntemleri ile genotiplendi. Sonuçlar istatistiksel yöntemlerle değerlendirildi. Bulgular: eNOS G894T ile COVID-19 hastalığı arasında anlamlı bir ilişki tespit edildi. eNOS G894T varyantı için, T/T genotipi ve T aleli taşıyıcılarının COVID-19 hastalığı için artan riske sahip olduğu görüldü (sırasıyla, p=0,035 ve p=0,030), eNOS G894T G/G genotipi, kontrol grubunda hasta grubuna göre daha yaygındı (p=0.030). eNOS VNTR genotipi ve allel frekansları açısından gruplar arasında anlamlı farklılık yoktu (p˃0.05). Bu varyantlar için hasta ve kontrol gruplarının genotipleri HWE’deydi. Sonuç: Bu sonuçlar, eNOS G894T varyantının Türk popülasyonunda artan COVID-19 riski ile ilişkili olduğu hipotezini destekleyen kanıtlar sağlamıştır. Bulgularımız yeni tedavi seçeneklerinin ortaya çıkmasına yol açabilir. Hastalığın patogenezinde yer alan moleküler mekanizmaları anlamak için daha fazla araştırmaya ihtiyaç vardır. Anahtar Kelimeler:

🔖

Cite This Article

ŞENKAL, N., OYACI, Y., CEBECİ, T., KONYAOĞLU, H., KÖSE, M., ÖNEL, M., MEDETALİBEYOĞLU, A., SAYIN, G. Y., PEHLİVAN, M., PEHLİVAN, S., İŞOĞLU-ALKAÇ, Ü., TÜKEK, T. (2023). ASSOCIATING eNOS GENE VARIANTS WITH COVID-19 SUSCEPTIBILITY IN THE TURKISH POPULATION. İstanbul Tıp Fakültesi Dergisi, Cilt: 86 - Sayı: 1, 1–6. https://ajindex.com/articles/886653

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020;324(8):782-93 [CrossRef] google scholar 2. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med 2020; 383: 2451-2460. [CrossRef] google scholar 3. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ and HLH Across Speciality Collaboration UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033-4. [CrossRef] google scholar 4. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417-8. [CrossRef] google scholar 5. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA 2020;323(13):1239-42. [CrossRef] google scholar 6. Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol 2020;20(7):389-91. [CrossRef] google scholar 7. Shankarishan P, Borah PK, Ahmed G, Mahanta J. Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population. Biomed Res Int 2014; 2014:793040. [CrossRef] google scholar 8. Vecoli C. Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease. Vitam Horm 2014;96:387-406. [CrossRef] google scholar 9. Abdul-Cader MS, Amarasinghe A, Abdul-Careem MF. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Arch Virol 2016;161(8): 2075-86. [CrossRef] google scholar 10. Akerström S, Mousavi-Jazi M, Klingström J, Leijon M, Lundkvist A, Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol 2005;79(3):1966-9. [CrossRef] google scholar 11. Zammiti W, Mtiraoui N, Mahjoub T. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in Tunisian women. Am J Reprod Immunol 2008;59:139-45. [CrossRef] google scholar 12. Joshaghani HR, Salehi A, Samadian E, Gharei R, Ahmadi AR. Association between NOS3 G894T, T-786C and 4a/4b variants and coronary artery diseases in Iranian population. Iran J Public Health 2018;47(12);1891-8. google scholar 13. Gelzo M, Scialò